Lombard Odier Asset Management (Europe) LTD Halozyme Therapeutics, Inc. Transaction History
Lombard Odier Asset Management (Europe) LTD
- $1.57 Billion
- Q3 2024
A detailed history of Lombard Odier Asset Management (Europe) LTD transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Lombard Odier Asset Management (Europe) LTD holds 125,000 shares of HALO stock, worth $5.87 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
125,000
Previous 200,000
37.5%
Holding current value
$5.87 Million
Previous $10.5 Million
31.71%
% of portfolio
0.46%
Previous 0.72%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$827 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$606 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$312 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$191 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$160 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.54B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...